282 related articles for article (PubMed ID: 26968522)
1. Biologic agents in juvenile spondyloarthropathies.
Katsicas MM; Russo R
Pediatr Rheumatol Online J; 2016 Mar; 14(1):17. PubMed ID: 26968522
[TBL] [Abstract][Full Text] [Related]
2. Juvenile spondyloartropathies.
Yıldız M; Haşlak F; Adroviç A; Şahin S; Barut K; Kasapçopur Ö
Eur J Rheumatol; 2022 Jan; 9(1):42-49. PubMed ID: 34101576
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for juvenile spondyloarthritis: an overview of the available therapies.
Marino A; De Souza M; Giani T; Cimaz R
Expert Opin Pharmacother; 2020 Dec; 21(17):2161-2168. PubMed ID: 32726179
[TBL] [Abstract][Full Text] [Related]
4. Juvenile Idiopathic Arthritis.
Barut K; Adrovic A; Şahin S; Kasapçopur Ö
Balkan Med J; 2017 Apr; 34(2):90-101. PubMed ID: 28418334
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of classification criteria for juvenile-onset spondyloarthropathies.
Kasapçopur O; Demirli N; Ozdoğan H; Apelyan M; Calişkan S; Sever L; Arisoy N
Rheumatol Int; 2005 Aug; 25(6):414-8. PubMed ID: 15034750
[TBL] [Abstract][Full Text] [Related]
6. A short-term follow-up of enthesitis and arthritis in the active phase of juvenile onset spondyloarthropathies.
Burgos-Vargas R; Pacheco-Tena C; Vázquez-Mellado J
Clin Exp Rheumatol; 2002; 20(5):727-31. PubMed ID: 12412210
[TBL] [Abstract][Full Text] [Related]
7. The performance of classification criteria for juvenile spondyloarthropathies.
Adrovic A; Sezen M; Barut K; Sahin S; Acikel C; Demirkaya E; Kasapcopur O
Rheumatol Int; 2017 Dec; 37(12):2013-2018. PubMed ID: 29018906
[TBL] [Abstract][Full Text] [Related]
8. Juvenile Spondyloarthritis: focus on uveitis.
Marino A; Weiss PF; Brandon TG; Lerman MA
Pediatr Rheumatol Online J; 2020 Sep; 18(1):70. PubMed ID: 32912296
[TBL] [Abstract][Full Text] [Related]
9. Retrospective study of juvenile spondylarthropathies in Croatia over the last 11 years.
Prutki M; Tambic Bukovac L; Jelusic M; Potocki K; Kralik M; Malcic I
Clin Exp Rheumatol; 2008; 26(4):693-9. PubMed ID: 18799108
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the treatment of the spondyloarthropathies.
Liu Y; Cortinovis D; Stone MA
Curr Opin Rheumatol; 2004 Jul; 16(4):357-65. PubMed ID: 15201597
[TBL] [Abstract][Full Text] [Related]
11. Rheumatic manifestations in inflammatory bowel disease.
Atzeni F; Defendenti C; Ditto MC; Batticciotto A; Ventura D; Antivalle M; Ardizzone S; Sarzi-Puttini P
Autoimmun Rev; 2014 Jan; 13(1):20-3. PubMed ID: 23774109
[TBL] [Abstract][Full Text] [Related]
12. Seronegative spondyloarthropathy-associated inflammatory bowel disease.
Wang CR; Tsai HW
World J Gastroenterol; 2023 Jan; 29(3):450-468. PubMed ID: 36688014
[TBL] [Abstract][Full Text] [Related]
13. Disease-modifying antirheumatic drug therapy for spondyloarthropathies: advances in treatment.
Mease PJ
Curr Opin Rheumatol; 2003 May; 15(3):205-12. PubMed ID: 12707572
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-23 pathway at the enthesis: The emerging story of enthesitis in spondyloarthropathy.
Bridgewood C; Sharif K; Sherlock J; Watad A; McGonagle D
Immunol Rev; 2020 Mar; 294(1):27-47. PubMed ID: 31957051
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment.
Fragoulis GE; Liava C; Daoussis D; Akriviadis E; Garyfallos A; Dimitroulas T
World J Gastroenterol; 2019 May; 25(18):2162-2176. PubMed ID: 31143068
[TBL] [Abstract][Full Text] [Related]
16. Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Giulio Favalli E; Becciolini A; Benucci M; Gobbi FL; Guiducci S; Foti R; Mosca M; Goletti D
Semin Arthritis Rheum; 2017 Oct; 47(2):183-192. PubMed ID: 28413099
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal lesions associated with spondyloarthropathies.
Orlando A; Renna S; Perricone G; Cottone M
World J Gastroenterol; 2009 May; 15(20):2443-8. PubMed ID: 19468992
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centre.
Goirand M; Breton S; Chevallier F; Duong NP; Uettwiller F; Melki I; Mouy R; Wouters C; Bader-Meunier B; Job-Deslandre C; Quartier P
Pediatr Rheumatol Online J; 2018 Apr; 16(1):21. PubMed ID: 29609643
[TBL] [Abstract][Full Text] [Related]
19. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.
Levy-Clarke G; Jabs DA; Read RW; Rosenbaum JT; Vitale A; Van Gelder RN
Ophthalmology; 2014 Mar; 121(3):785-96.e3. PubMed ID: 24359625
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic imaging of sacroiliac joints and the spine in the course of spondyloarthropathies.
Sudoł-Szopinska I; Urbanik A
Pol J Radiol; 2013 Apr; 78(2):43-9. PubMed ID: 23807884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
